BioMarin Pharmaceutical Inc. (BMRN)
Biotechnology · Healthcare · $10.6B
Intrinsic Value (Consensus)
$36.35
Current Price
$54.71
Margin of Safety
-33.6%
33.6% Above Intrinsic Value
Value: $36
Price: $55
Valuation Model Estimates
Current Price: $54.71
DCF (Discounted Cash Flow)
$72.92
Graham Number
$30.95
Earnings Power Value
$18.52
Relative Value (P/E)
$23.00
Dividend Discount Model
Not applicable
—
Consensus Value
$36.35
Model Assumptions
Discount Rate
10.3%
Growth Rate
17.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
66
Profitability
15/25
Strength
25/25
Valuation
7/25
Growth
19/25
Financial Health Signals
Low debt — conservative balance sheet
Strong earnings growth (17% YoY)
Key Financials
- EPS (TTM)
- $1.35
- EPS (Forward)
- $1.58
- Book Value
- $31.49
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 5.7%
- Debt/Equity
- 23%
- Revenue Growth
- 12.9%
- Earnings Growth
- 17.0%
- Dividend Yield
- N/A
- Beta
- 0.26
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance